Anne-Els van de Logt

ResearcherPublications, citations & collaboration network

Anne-Els van de Logt is a researcher indexed in ScholarIQ from OpenAlex & ORCID. ScholarIQ records 53 works, 1,298 citations, an h-index of 16 and an i10-index of 17.

Works

1,298

Citations

h-index

i10-index

IDs:OpenAlex

How has Anne-Els van de Logt's publication output changed over time?

ScholarIQpublication output · 2015–2021

Output grew0% over the shown period — from 1 works in 2015 to 1 in 2021.

201520162018201920202021

What are the most-cited papers on Anne-Els van de Logt?

ScholarIQmost cited works

The STARMEN trial indicates that alternating treatment with corticosteroids and cyclophosphamide is superior to sequential treatment with tacrolimus and rituximab in primary membranous nephropathy

Gema Fernández‐Juárez, Jorge Rojas-Rivera, Anne-Els van de Logt, Joana Justino, Ángel Sevillano, Fernando Caravaca‐Fontán, Ana Ávila, Cristina Rabasco, Virginia Cabello, Alfonso Varela, Montserrat Díez, Guillermo Martín-Reyes, Marian Goicoechea Diezhandino, Luís F. Quintana, Irene Agraz, Juan Ramón Gomez-Martino, Mercedes Cao, Antolina Rodríguez-Moreno, Begoña Rivas, C. Galéano, J. Vilar Bonet, Ana Romera, Amir Shabaka, Emmanuelle Plaisier, Mario Espinosa, Jesús Egido, Alfonso Segarra, Gérard Lambeau, Pierre Ronco, Jack F.M. Wetzels, Manuel Praga, Manuel Praga, Ángel Sevillano, Fernando Caravaca‐Fontán, Hernando Trujillo, Eduardo Gutiérrez, Gema Fernández Juárez, Amir Shabaka, Jorge Rojas-Rivera, Jesús Egido, Alberto Ortíz, Marián Goicoechea, Úrsula Verdalles, Alfons Segarra, Irene Agraz, Guillermo Martín-Reyes, Lara Perea, Ildefonso Valera, Mónica Martín, Virginia Cabello, Miguel Ángel Pérez Valdivia, Luís F. Quintana, Miquel Blasco, Mercedes Cao, Andrés López Muñíz, Ana Ávila, T Małek, Mario Espinosa, Cristina Rabasco, Montserrat Díaz, Iara daSilva, Jordi Bonet, Maruja Navarro, Juan Ramón Gomez-Martino, Begoña Rivas, Antolina Rodríguez-Moreno, C. Galéano, Ana Romera, Ana Huerta, E. Rodriguez-Paternina, Ana Vigil, Roberto Alcázar, Vicente Paraíso, V. Barrio, Jack F.M. Wetzels, Anne-Els van de Logt, Julia M. Hofstra

Kidney International. 2020241 CitationsOPEN ACCESS

The anti-PLA2R antibody in membranous nephropathy: what we know and what remains a decade after its discovery

Anne-Els van de Logt, Maryline Fresquet, Jack F.M. Wetzels, Paul Brenchley

Kidney International. 2019197 CitationsOPEN ACCESS

Novel ELISA for thrombospondin type 1 domain-containing 7A autoantibodies in membranous nephropathy

Christelle Zaghrini, Barbara Seitz‐Polski, Joana Justino, Guillaume Dolla, Christine Payré, Noémie Jourde‐Chiche, Anne-Els van de Logt, Caroline Booth, Emma Rigby, Jennie Lönnbro-Widgren, Jenny Nyström, Christophe Mariat, Zhao Cui, Jack F.M. Wetzels, Gian Marco Ghiggeri, Laurence H. Beck, Pierre Ronco, Hanna Dêbiec, Gérard Lambeau

Kidney International. 201988 CitationsOPEN ACCESS

Immunological remission in PLA2R-antibody–associated membranous nephropathy: cyclophosphamide versus rituximab

Anne-Els van de Logt, Karine Dahan, Alexandra Rousseau, Renate G. van der Molen, Hanna Dêbiec, Pierre Ronco, Jack F.M. Wetzels

Kidney International. 201887 CitationsOPEN ACCESS

Serum anti-PLA2R antibodies can be initially absent in idiopathic membranous nephropathy: seroconversion after prolonged follow-up

Anne-Els van de Logt, Julia M. Hofstra, Jack F.M. Wetzels

Kidney International. 201575 CitationsOPEN ACCESS